There are 15,360 results relating to "Medicin Viagra-m"
Order by
|
Official Report
Meeting date:
24 February 2026
Equalities, Human Rights and Civil Justice Committee 24 February 2026 [Draft]
It might be useful if I invite Robby Steel to offer a few thoughts and reflections on the broader question of diagnosis and the important role that it can play. Diagnosis in the whole of medicine is a bit more complicated than is often portrayed.
Official Report
Meeting date:
17 March 2022
COVID-19 Recovery Committee 17 March 2022
I want to pick up on the issue of emergency medicine, which we have not touched on much this morning.
Questions and Answers
Date answered:
20 January 2021
S5W-34271
To ask the Scottish Government whether it will adjust training allocations in (a) geriatrics, (b) neurology, (c) renal, (d) respiratory and (e) rheumatology medicine in the North of Scotland NHS region to ensure that these programmes meet the region’s 15% allocation of higher specialty training places.
Questions and Answers
Date answered:
27 August 2019
S5W-24705
The purpose of these meetings has been to seek to develop the principles of a solution that can make possible the widest availability of these medicines, wherever clinically appropriate.
Questions and Answers
Date answered:
5 March 2019
S5W-21611
We strongly encourage clinicians to make use of this system where they judge a medicine, such as Orkambi, to be appropriate for their individual patient’s needs and we expect NHS Boards to process applications appropriately as is set out in the national guidance.
Questions and Answers
Date answered:
21 August 2018
S5W-17925
The open data files are available at the following link - https://www.opendata.nhs.scot/dataset/prescriptions-in-the-community . The Essential Medicines Buffer Stock is the mechanism for stockpiling medicines (including insulin) for emergency purposes, such as a disruption to the supply line or a pandemic.
Questions and Answers
Date answered:
29 May 2018
S5W-16724
Scottish Government officials meet with DHSC colleagues to discuss medicine supply issues on a regular basis and will continue to do so.
Questions and Answers
Date answered:
18 January 2018
S5W-13662
Regulation for the licensing, safety and efficacy of medicines is currently reserved to the UK Government and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA) who operate on a UK wide basis.
Official Report
Meeting date:
8 October 2025
Citizen Participation and Public Petitions Committee 08 October 2025
I suggest that we invite the Minister for Public Health and Women’s Health to give evidence on the matter, and that we invite the British Association of Perinatal Medicine’s best start perinatal sub-group to the committee so that we can interrogate the process that led to the recommendation for three rather than four or five units.
Last updated:
30 January 2024
Major Capital Projects Progress Update Jan 2024
It will also include a Neonatal Unit (NNU), accommodation for reproductive services, an operating theatre suite, a Commercial Medicines Unit (CMU) and research and teaching facilities.
